[(Name of Issuer) Common Stock (Title of Class of Securities) G45667105 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. G45667105 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A ]
[SCHEDULE 13G CUSIP No. G21182 103 1 NAMES OF REPORTING PERSONS Sherman Holdings Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP £ (a) £ (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Commonwealth of the Bahamas NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: ]
[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A ]
[(Name of Issuer) Common Stock (Title of Class of Securities) G45667105 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. G45667105 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A ]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 5, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province]
[filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be otherwise subject to t]
[Joint Filing Agreement Jinbo Yao Nihao China Corporation] [Jinbo Yao 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) ¨ (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF 5 SOLE VOTING POWER 2,272,960 ordinary shares. See Item 4. 6 SHARED VOTING PO]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 5, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province]
[filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be otherwise subject to t]
